Cystic fibrosis: bacterial pathogenesis and CFTR (cystic fibrosis transmembrane conductance regulator) modulators

被引:0
|
作者
Vargas-Roldan, Silvia Y. [1 ,2 ]
Lezana-Fernandez, Jose L. [3 ,4 ]
Cerna-Cortes, Jorge F. [2 ]
Partida-Sanchez, Santiago [5 ,6 ]
Santos-Preciado, Jose, I [1 ]
Rosales-Reyes, Roberto [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Ciudad De Mexico, Mexico
[2] Inst Politecn Nacl, Dept Microbiol, Lab Microbiol Mol, Escuela Nacl Ciencias Biol, Ciudad De Mexico, Mexico
[3] Hosp Infantil Mexico Dr Federico Gomez, Lab Fisiol Respiratoria & Clin Fibrosis Quist, Ciudad De Mexico, Mexico
[4] Assoc Mexicana Fibrosis Quist, Direcc Med, Ciudad De Mexico, Mexico
[5] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Abigail Wexner Res Inst, Columbus, OH USA
[6] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
来源
BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO | 2022年 / 79卷 / 04期
关键词
Cystic fibrosis; Pseudomonas aeruginosa; Burkholderia cenocepacia; CFTR modulators; VI SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; ADAPTATION; POTENTIATOR; IVACAFTOR;
D O I
10.24875/BMHIM.21000128
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cystic fibrosis is an autosomal recessive inherited disease caused by mutations in the cystic fibrosis transmembrane con-ductance regulator gene (CFTR). CFTR is a protein that transports ions across the membrane of lung epithelial cells. Loss of its function leads to the production of thick sticky mucus, where various bacterial pathogens can establish and adapt, contributing to the gradual loss of lung function. In this review, evidence of the molecular mechanisms used by Pseudomonas aeruginosa and Burkholderia cenocepacia to survive and persist in the pulmonary environment will be provided. Additionally, new therapeutic strategies based on CFTR function modulators will be described.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 50 条
  • [21] Effectiveness and Safety of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Children With Cystic Fibrosis: A Meta-Analysis
    Li, Qiyu
    Liu, Siyuan
    Ma, Xuemei
    Yu, Jiaping
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [22] A Developmental Role of the Cystic Fibrosis Transmembrane Conductance Regulator in Cystic Fibrosis Lung Disease Pathogenesis
    Huang, Elena N.
    Quach, Henry
    Lee, Jin-A
    Dierolf, Joshua
    Moraes, Theo J.
    Wong, Amy P.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [23] Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
    Ramsey, Mitchell L.
    Wellner, Michael R.
    Porter, Kyle
    Kirkby, Stephen E.
    Li, Susan S.
    Lara, Luis F.
    Kelly, Sean G.
    Hanje, A. James
    Sobotka, Lindsay A.
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (02) : 411 - 419
  • [24] The Role of Cystic Fibrosis Transmembrane Conductance Regulator Modulators After Liver Transplantation in Persons With Cystic Fibrosis
    Maradiaga, Richard
    Ramsey, Mitchell
    Kirkby, Stephen
    Sobotka, Lindsay
    ACG CASE REPORTS JOURNAL, 2024, 11 (01)
  • [25] Cystic Fibrosis Transmembrane Conductance Regulator-Modifying Medications: The Future of Cystic Fibrosis Treatment
    Pettit, Rebecca S.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (7-8) : 1065 - 1075
  • [26] Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis
    Ooi, Chee Y.
    Durie, Peter R.
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (05) : 355 - 362
  • [27] Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
    Harwood, Kiera H.
    McQuade, Rachel M.
    Jarnicki, Andrew
    Schneider-Futschik, Elena K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [28] EXCESS FLUORIDE INTERFERENCE WITH CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)
    Clinch, Carole
    FLUORIDE, 2011, 44 (01) : 7 - 8
  • [29] Cystic Fibrosis Transmembrane Regulator Modulators: Implications for the Management of Depression and Anxiety in Cystic Fibrosis
    Talwalkar, Jaideep S.
    Koff, Jonathan L.
    Lee, Hochang B.
    Britto, Clemente J.
    Mulenos, Arielle M.
    Georgiopoulos, Anna M.
    PSYCHOSOMATICS, 2017, 58 (04) : 343 - 354
  • [30] The effect of triple therapy cystic fibrosis transmembrane conductance regulator (CFTR) modulation on anxiety in people with cystic fibrosis
    O'Carroll, O.
    McKeown, C.
    Bell, J.
    Nicholson, T.
    Gallagher, C.
    McKone, E.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60